Medicines A-to-Z

Medicines A–Z

Drug name	NICE TAs	Comments
Dabigatran capsules	TA249 - Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation TA327 - Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism	Following diagnosis of AF – use in line NICE.
Dabigatran capsules #2.8	TA327 - Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism	For the treatment and secondary prevention of DVT and/or PE - use in line with NICE. Initiation/recommendation by haematologist.GP with RICaD. Adults only
Dabrafenib	TA321 - Dabrafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma TA544 - Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma
Dabrafenib with trametinib	TA898 - Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer
Dacarbazine injection		For hospital use only
Daclizumab concentrate for infusion	TA441 - Daclizumab for treating relapsing–remitting multiple sclerosis	For Hospital Use Only. Please see drug safety alert. Safety alert
Dacomitinib	TA595 - Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancer
Dactinomycin injection		For hospital use only
Daktacort cream	TA85 - Frequency of application of topical corticosteroids for atopic eczema	Mild potency
Danaparoid injection		Hospital use only